The proposal also advises that the supply of a different insulin medicine, NovoMix 30, is due to end in 2026. Both medicines are supplied by the same company, Novo Nordisk. Heyes says Pharmac ...

That suggests its top-selling insulin products like rapid-acting NovoRapid (insulin aspart), premix NovoMix (insulin aspart/insulin aspart protamine) and long-acting Tresiba (insulin degludec ...

South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over their insulin pen market practices, amid growing concerns about ...

They were eligible if their physician believed that they required insulin therapy ... Denmark] and NovoMix 30 FlexPen® 100 IU/ml suspension for injection in a prefilled pen [Novo Nordisk ...